Sabrina Johnson | President and Chief Executive Officer |
Lisa Walters-Hoffert | Chief Financial Officer |
John Fair | Chief Strategy Officer |
Kumaraguru Raja | ROTH Capital |
Welcome to the conference call hosted by Dare Bioscience to review the company's financial results for the quarter ended September 30, 2022 and to provide a general business update. This call is being recorded. My name is Paula and I will be your operator today. With us today are Sabrina Martucci Johnson, Dare's President and Chief Executive Officer; John Fair, Dare's Chief Strategy Officer; and Lisa Walters-Hoffert, Dare's Chief Financial Officer. Ms.